Research Article
PPAR-α Agonist Fenofibrate Decreased Serum Irisin Levels in Type 2 Diabetes Patients with Hypertriglyceridemia
Figure 1
Baseline serum irisin levels in the study participants. The values are expressed as the means ± SD. Group A: type 2 diabetes patients with hypertriglyceridemia (). Group B: control subjects ().